Portfoliotracker

Hamlet BioPharma AB (publ)

HAMLET-B.ST · STOCKHOLM · Healthcare Biotechnology 22/100 E

6,080 SEK
▲ +0,100 (+1,67 %)
Trading
Price as of 30. 9. 17:29, fetched 17. 11. 13:38
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score22 / 100 Market cap893 mil. SEK P/E– Forward P/E– P/S– P/B45,3 EV/EBITDA– Dividend yield– FCF yield-5,00 % EPS-0,30 SEK Net margin0,0 % Return on equity-198,3 % Beta0,35 Debt / equity–
52-week range 4,35 to 8,96
3-month average volume0,1 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Hamlet BioPharma AB (publ) engages in the development of drugs for the treatment and prevention of cancer and infections in Sweden. The company is developing Alpha1H for the treatment of bladder cancer; and IL-1 receptor antagonist (anakinra) for the treatment of bladder pain syndrome and recurrent acute cystitis that are in Phase II clinical trials, as well as Alpha1H for the treatment of brain tumor; Hamlet for the treatment of colon and rectal cancer and oral cancer; RNA Pol II inhibitor – protein for preventive anti-inflammatory and antibacterial effects; RNA Pol II inhibitor – bacteria for prevention of inflammation and treatment of infection; IRF7 inhibitor, siRNA for prevention of inhibits severe bacterial infections; and Anti-TBC peptide for prevention of pulmonary tuberculosis that are in preclinical stage. It has a collaboration agreement with University of Iowa for development of Alpha1H for patients with severe bladder cancer. Hamlet BioPharma AB (publ) was formerly known as Hamlet Pharma AB (publ) and changed its name to Hamlet BioPharma AB (publ) in August 2023. The company was incorporated in 1999 and is based in Lund, Sweden. Hamlet BioPharma AB (publ) operates as a subsidiary of Linnane Pharma AB.

Employees
6
Country
Sweden
Data since
23. 10. 2015

Explore further

Similar companies VICO.STKEMPOWR.HE

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account